MINNEAPOLIS — Switching candidates for implantable cardioverter-defibrillator (ICD) implantation to a dual-function device that also modulates cardiac contractility was associated with successful ...

May 27, 2005-- Guidant Corporation (Indianapolis, Indiana) sent a letter to physicians this week informing them about a potential shorting defect in certain models of the company's PRIZM 2 DR ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

The heart is a finely tuned machine, pumping and squeezing to move blood through the body with a fresh supply of oxygen and nutrients. Electrical activity provides the spark to coordinate and activate ...

The S-ICD system with no leads in the heart When Boston Scientific announced its acquisition of Cameron Health in early 2012, it proclaimed that Cameron's subcutaneous ICD device with no leads in the ...

If you have hypertrophic cardiomyopathy (HCM), and especially if you have obstructive HCM that reduces blood flow out of your heart, you and your doctor may discuss ways to lower your risk of sudden ...

In an interview, a senior Boston Scientific executive shares new information on the company's competing device to Medtronic's Micra and St. Jude Medical's Nanostim leadless pacemakers. We know about ...

A new Mayo Clinic study questions the benefit of implantable cardioverter-defibrillator use to treat patients with transthyretin cardiac amyloidosis. For patients with transthyretin cardiac ...